Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Alder, Umia and the founders in connection with the sale of Umia Innovation to TSG
Mandate

Vinge advises Alder, Umia and the founders in connection with the sale of Umia Innovation to TSG

September 15, 2023 M&A

Vinge has advised Alder, Umia and the founders in connection with the sale of Umia Innovation to The Specialist Group (TSG), a portfolio company of Oaktree Capital Management.

Umia Innovation, with offices located in Umeå, Skellefteå och Örnsköldsvik, provides knowledge-based consultancy services within processing, technology and leadership. The company has customers within, among other things, the mining industry, forestry, medical technology, the car industry and the energy sector. Umia Innovation has changed its name to Altio in connection with the transaction.

Vinge’s team primarily consisted of Johan Larsson, Karl Klackenberg, Ellinor Wargenbrant, Carl Fredrik Wachtmeister, Robin Fagerström (M&A), as well as Jessica Henning and Emy Rydén (project assistants).

Related

Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

 A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023